4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-248967
See Remarks sold 75,000 shares at an average $65.59 ($4,918,944)
- See Remarks acquired 75,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Maduck Sean See Remarks | 2026-05-27 | Option exercise 10b5-1 | +75,000 | $8.27 | $620,250 | 83,977 | D: show line 1 in the form |
| Maduck Sean See Remarks | 2026-05-27 | Sale 10b5-1 | −54,575 | $65.37 | $3,567,628 | 29,402 | D: show line 2 in the form |
| Maduck Sean See Remarks | 2026-05-27 | Sale 10b5-1 | −20,425 | $66.16 | $1,351,316 | 8,977 | D: show line 3 in the form |
| Open-market sales · 75,000 sh · avg $65.59 · $4,918,944 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Maduck Sean See Remarks | 2026-05-27 | Option exercise · Stock option (right to buy) 10b5-1 | −75,000 | 166,986 | D: show line 4 in the form |
Loading xslF345X06/ownership.xml…